Mike Geddis

Transnetyx is an automated genotyping company dedicated to serving research and saving time by removing redundant, yet necessary, tests conducted in genetic research.

• Sell Genotyping and Mouse colony management software into research laboratories
• Managed highest revenue territory in North America(3 million annual revenue 2023)

Invitae is building the genetics platform to support a new age in medicine, using the power of genomic information.

• Sell genetic testing into oncology market in Rhode Island and Massachusetts
• Consult with genetic counselors on role of genetic testing to identify inherited diseases

The Company offers genetic testing menu includes screening and diagnosis for exome, epilepsy, cancer, cardiovascular and rare disease, and neurodevelopmental disorders.

• Sell genetic testing to pediatric neurologists and cardiologists in New England Region ·
• Consult with genetic counselors on role of genetic testing to identify inherited diseases ·
• Northeast Rookie of the Year Fiscal 2019(120% to Quota)
• Attained 100% of Quota Fiscal 2020

• Sell Lifevest(wearable cardioverter defibrillator) into hospital market and alternate sites of care
• 2016 Rookie of the Year in Northeast Region
• Consult with Interventional cardiologists, Electrophysiology Physicians, and general cardiologists on Lifevest and prevention of Sudden Cardiac Arrest